Get ready for an exciting webinar from Fascination Allergology! This time, we are thrilled to welcome Prof. Mohamed Shamji (MD), a renowned allergist and immunologist, as our guest speaker.
In this session, Prof. Shamji will explore how artificial intelligence (AI) is revolutionizing allergen immunotherapy. From enhancing diagnostic precision to personalizing treatment plans, AI is shaping the future of allergy care.
Following a brief keynote presentation, you’ll have the opportunity to engage directly with Prof. Shamji. Whether you have practical, scientific, or career-related questions, this is your chance to gain valuable insights from an expert at the forefront of innovation in AIT.
Our dynamic moderators, Prof. Ann-Marie Schoos (Denmark) and Sebastian Seurig (Germany), will guide the session with their signature blend of professionalism and curiosity, ensuring a lively and interactive discussion.
Already have a question for Prof. Shamji? Send it to us in advance at fascination-allergology@alk.net.
Quick Overview:
Guest Speaker: Prof. Mohamed Shamji (MD)
Topic: The Future of Allergology: How Artificial Intelligence is Transforming Treatment
Moderation: Prof. Ann-Marie Schoos (MD), Sebastian Seurig (MD)
Agenda
Keynote Presentation: "The Future of AlIergology: How Artificial Intelligence is Transforming Treatment" (Prof. Mohamed Shamji)
Allergology Case Study: A practical example to deepen understanding (Prof. Mohamed Shamji)
Open Discussion: Interactive Q&A session with participants (Prof. Mohamed Shamji, Prof. Ann-Marie Malby Schoos, Sebastian Seurig)
Presenters
Prof. Mohamed Shamji
Professor of Immunology and Allergy at Imperial College London
Prof. Shamji completed his clinical scientist fellowship training in clinical immunology at the Chelsea & Westminster Hospital NHS Foundation Trust in London, United Kingdom (UK) in 2004. He then pursued his interest in translational research and completed his PhD studies in allergy and clinical immunology at the National Heart & Lung Institute, Imperial College London, UK in 2010. He established his research group (Immunomodulation and Tolerance group) within Allergy and Clinical Immunology at Imperial College lead by Professor Stephen Durham.
Dr Shamji has a specific interest in respiratory allergies, especially how disease-modifying treatments such as allergen immunotherapy, novel biologics and novel immunomodulators (Toll Like Receptor (TLR) 7 and Surfactant protein (SP)-D) affect immunologic (T, B cell and immunoglobulins) responses leading to induction of immune tolerance, as well as the investigation of novel surrogate/predictive biomarkers of clinical outcome following immunotherapy.
He is actively involved in evaluating novel approaches of allergen immunotherapy using modified hypoallergic form of allergen protein, subcutaneous immunotherapy in combination with novel adjuvants, sublingual immunotherapy, peptide immunotherapy, biologics plus allergen of interest strategies to improve safety, efficacy and induce immune tolerance to sensitising allergen.
Prof. Ann-Marie Malby Schoos
MD, PhD, DMSc, pediatrician and Research Associate Professor
Sebastian Seurig
Hey, my name is Sebastian.
I am a resident physician in internal medicine and pulmonology and serve as the coordinator of the Nuremberg Interdisciplinary Center for Allergology.
Allergology has fascinated me since my first clinical clerkship during medical school. I value the opportunity to care for patients of all ages with diverse symptoms affecting multiple organ systems in an interdisciplinary, longitudinal manner. In addition to a thorough history and physical examination, care often involves complex laboratory diagnostics and the use of modern therapeutics.
Since the start of my research with neural networks, I have been exploring and investigating intersections with allergology. Clinically, I primarily care for patients with immediate‑type (Type I) allergies, and I teach allergology and asthma within the undergraduate medical curriculum.